FDA Approves Optimer's DIFICID™ (fidaxomicin) Tablets for the Treatment of Patients with Clostridium difficile-Associated Diarrhea (CDAD)
Optimer Pharmaceuticals, Inc.
John D. Prunty, Chief Financial Officer & Senior Vice President, Finance
Canale Communications, Inc.
Jason I. Spark, Senior Vice President
You May Also Like